Spinal cord involvement is an important cause of disability in patients with multiple sclerosis or neuromyelitis optica spectrum disorders (NMOSDs). Multiple sclerosis and NMOSDs can be distinguished from other disorders that cause myelopathy by results from laboratory and radiological investigations. However, limitations in the sensitivity and specificity of spinal cord imaging and poor correlation with disability megasures have impeded the understanding of the relationship between spinal cord involvement and clinical manifestations. Nevertheless, studies of the pathological features of multiple sclerosis and NMOSDs have shown that quantitatively different mechanisms lead to differences in clinical course and pattern of accrual of permanent disability in the two disorders. Better understanding of these mechanisms is necessary to develop more informative clinical measures, electrophysiological methods, fluid biomarkers, and imaging techniques to detect and monitor spinal cord involvement in the diagnosis and management of patients with multiple sclerosis or NMOSDs, and as outcome measures in clinical trials.

Ciccarelli, O., Cohen, J.A., Reingold, S.C., Weinshenker, B.G., Amato, M.P., Banwell, B., et al. (2019). Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders. LANCET NEUROLOGY, 18(2), 185-197 [10.1016/S1474-4422(18)30460-5].

Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders

De Stefano, Nicola;
2019-01-01

Abstract

Spinal cord involvement is an important cause of disability in patients with multiple sclerosis or neuromyelitis optica spectrum disorders (NMOSDs). Multiple sclerosis and NMOSDs can be distinguished from other disorders that cause myelopathy by results from laboratory and radiological investigations. However, limitations in the sensitivity and specificity of spinal cord imaging and poor correlation with disability megasures have impeded the understanding of the relationship between spinal cord involvement and clinical manifestations. Nevertheless, studies of the pathological features of multiple sclerosis and NMOSDs have shown that quantitatively different mechanisms lead to differences in clinical course and pattern of accrual of permanent disability in the two disorders. Better understanding of these mechanisms is necessary to develop more informative clinical measures, electrophysiological methods, fluid biomarkers, and imaging techniques to detect and monitor spinal cord involvement in the diagnosis and management of patients with multiple sclerosis or NMOSDs, and as outcome measures in clinical trials.
2019
Ciccarelli, O., Cohen, J.A., Reingold, S.C., Weinshenker, B.G., Amato, M.P., Banwell, B., et al. (2019). Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders. LANCET NEUROLOGY, 18(2), 185-197 [10.1016/S1474-4422(18)30460-5].
File in questo prodotto:
File Dimensione Formato  
328.pdf

non disponibili

Descrizione: Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders.
Tipologia: PDF editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 5.86 MB
Formato Adobe PDF
5.86 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1071782